Senores Pharmaceuticals Limited
SENORES.NS- 1D
- +2.0%
Senores Pharmaceuticals Limited in brief
Senores Pharmaceuticals Limited is a listed company in the Healthcare sector, based in India. Its market value was $549 M on 19 November 2026, which makes it the 12,160th largest listed company in the world and the 849th largest in India on this site. Its shares trade under the symbol SENORES.NS (NSE).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Senores Pharmaceuticals Limited timeline
- 2024
- 📈Listed on National Stock Exchange of India as SENORESFirst day of listing in the exchange's official list.
Events of Senores Pharmaceuticals Limited from the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Senores Pharmaceuticals Limited share price · NSE (SENORES.NS)
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Nov 19, 2026 | 1,087 | 1,125 | 1,079 | 1,113 | +1.9% | 237,313 |
| Nov 18, 2026 | 1,139 | 1,146 | 1,083 | 1,093 | -4.0% | 406,925 |
| Nov 17, 2026 | 1,148 | 1,165 | 1,134 | 1,139 | -0.8% | 154,847 |
| Nov 16, 2026 | 1,175 | 1,186 | 1,143 | 1,148 | -2.3% | 139,529 |
| Nov 13, 2026 | 1,208 | 1,227 | 1,165 | 1,175 | -3.5% | 409,497 |
| Nov 12, 2026 | 1,173 | 1,222 | 1,173 | 1,217 | +3.7% | 202,580 |
| Nov 11, 2026 | 1,175 | 1,187 | 1,161 | 1,173 | -0.2% | 166,000 |
| Nov 9, 2026 | 1,199 | 1,220 | 1,170 | 1,175 | +1.2% | 155,540 |
| Nov 6, 2026 | 1,185 | 1,185 | 1,130 | 1,161 | -2.3% | 274,945 |
| Nov 5, 2026 | 1,143 | 1,205 | 1,136 | 1,188 | +4.5% | 348,940 |
| Nov 4, 2026 | 1,143 | 1,155 | 1,125 | 1,137 | -0.9% | 134,487 |
| Nov 3, 2026 | 1,115 | 1,165 | 1,096 | 1,147 | +2.4% | 347,256 |
| Nov 2, 2026 | 1,146 | 1,152 | 1,094 | 1,120 | -1.3% | 505,488 |
| Oct 30, 2026 | 1,219 | 1,228 | 1,053 | 1,134 | -7.0% | 2.3 M |
| Oct 29, 2026 | 1,324 | 1,340 | 1,208 | 1,219 | -7.9% | 1.1 M |
| Oct 28, 2026 | 1,315 | 1,341 | 1,310 | 1,324 | +1.0% | 186,875 |
| Oct 27, 2026 | 1,255 | 1,318 | 1,249 | 1,311 | +5.3% | 204,236 |
| Oct 26, 2026 | 1,220 | 1,260 | 1,210 | 1,246 | +2.5% | 158,092 |
| Oct 23, 2026 | 1,211 | 1,221 | 1,168 | 1,215 | +1.1% | 165,744 |
| Oct 22, 2026 | 1,202 | 1,243 | 1,195 | 1,203 | -1.8% | 182,678 |
| Oct 21, 2026 | 1,254 | 1,255 | 1,196 | 1,224 | -2.4% | 303,198 |
| Oct 19, 2026 | 1,324 | 1,345 | 1,241 | 1,254 | -4.9% | 249,045 |
| Oct 16, 2026 | 1,259 | 1,324 | 1,254 | 1,318 | +4.7% | 286,388 |
| Oct 15, 2026 | 1,281 | 1,297 | 1,254 | 1,259 | -1.8% | 159,308 |
| Oct 14, 2026 | 1,321 | 1,325 | 1,271 | 1,282 | -3.0% | 145,695 |
| Oct 13, 2026 | 1,319 | 1,332 | 1,287 | 1,321 | +0.2% | 168,254 |
| Oct 12, 2026 | 1,335 | 1,349 | 1,311 | 1,319 | -0.1% | 130,501 |
| Oct 9, 2026 | 1,329 | 1,344 | 1,306 | 1,320 | -0.4% | 141,415 |
| Oct 8, 2026 | 1,390 | 1,393 | 1,311 | 1,326 | -4.6% | 299,845 |
| Oct 7, 2026 | 1,400 | 1,424 | 1,380 | 1,390 | — | 197,473 |
Prices in INR from the National Stock Exchange of India; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.
Senores Pharmaceuticals Limited share price statistics
Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.
Market cap history
World rank over time
Rank in India: #817 (Nov 2026) · #838 (Nov 2026) · #840 (Nov 2026) · #843 (Nov 2026) · #853 (Nov 2026) · #849 (Nov 2026)
Mutual funds holding Senores Pharmaceuticals Limited#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Avantis Emerging Markets Equity ETFAmerican Century ETF Trust | 68,854 | $1 M | — | <0.01% | no change | May 31, 2026 |
| 🇮🇳 Motilal Oswal Nifty Microcap 250 Index FundMotilal Oswal Asset Management | 59,410 | $1 M | — | 0.31% | −1.9% | Oct 31, 2026 |
| 🇺🇸 State Street SPDR S&P Emerging Markets Small Cap ETFSSGA Funds Management, Inc. | 9,557 | $0 M | — | 0.02% | no change | Jun 30, 2026 |
| 🇺🇸 VanEck India Growth Leaders ETFVan Eck Associates Corporation | 12,860 | $0 M | — | 0.10% | — | Mar 31, 2026 |
| 🇺🇸 Avantis Emerging Markets ex-China Equity ETFAmerican Century ETF Trust | 2,054 | $0 M | — | <0.01% | no change | May 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Oct 31, 2026. The 5 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
FDA drug approvals: Senores Pharmaceuticals Limited#
1 approved applications held; 1 approvals and 0 new uses in 2026.
| Approved | Drug | Kind |
|---|---|---|
| 2026-10-26 | Propranolol HydrochloridePropranolol Hydrochloride · ANDA216072 | Generic drug (ANDA) |
Source: Drugs@FDA (openFDA). Approvals are listed under the application's current holder (SENORES PHARMS), so they follow acquisitions
Discuss Senores Pharmaceuticals Limited#
1 automatic updates and 0 member comments. Sign in to comment and react.
- Mutual funds: 5 funds hold $2 millionautomatic update · Oct 31, 2026
5 mutual funds in 2 countries hold shares of Senores Pharmaceuticals Limited worth $2 million (funds' newest reports, up to 31 October 2026). Since their previous reports 0 funds added shares and 1 sold; on balance they sold $10,000. Share splits are not counted as trading.
How Senores Pharmaceuticals Limited compares in Healthcare
- Market cap$549 M · higher than 47% of 2,013
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Senores Pharmaceuticals Limited🇮🇳 | $549 M | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
Sources and freshness
- Market cap:
- Nov 19, 2026
- Profile updated:
- Nov 20, 2026
Figures from Market data, value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Senores Pharmaceuticals Limited? Verify and update this profile — free
Show Senores Pharmaceuticals Limited's ranking on your website Get the badge
The badge updates itself as the ranking changes.